Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Nishiga

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Circulation Research|June 24, 2021
Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19Masataka Nishiga, Joseph C Wu
European Heart Journal|March 17, 2018
Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesiclesMasataka Nishiga, Hongchao Guo, Joseph C Wu
Advanced Drug Delivery Reviews|February 25, 2020
Therapeutic genome editing in cardiovascular diseasesMasataka Nishiga, Lei S Qi, Joseph C Wu
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2021
CRISPRi/a Screening with Human iPSCsMasataka Nishiga, Lei S Qi, Joseph C Wu
Circulation Research|March 31, 2022
Ferroptosis of Pacemaker Cells in COVID-19Masataka Nishiga, James W S Jahng, Joseph C Wu
Nature Reviews. Cardiology|February 11, 2022
The use of new CRISPR tools in cardiovascular research and medicineMasataka Nishiga, Chun Liu, Lei S Qi, et al.
Trends in Genetics : TIG|September 12, 2021
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCsHongchao Guo, Lichao Liu, Masataka Nishiga, et al.
Cardiovascular Intervention and Therapeutics|April 15, 2014
Acute myocardial infarction and 30-year coronary aneurysm follow-up by serial angiography in a young adult with Kawasaki diseaseKazuki Matsushita, Toshihiro Tamura, Masataka Nishiga, et al.
Nature Reviews. Cardiology|July 22, 2020
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectivesMasataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews. Drug Discovery|May 15, 2024
Tackling the challenges of new approach methods for predicting drug effects from model systemsPaul D Pang, Syed Mukhtar Ahmed, Masataka Nishiga, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Circulation Research|June 24, 2021
Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19Masataka Nishiga, Joseph C Wu
European Heart Journal|March 17, 2018
Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesiclesMasataka Nishiga, Hongchao Guo, Joseph C Wu
Advanced Drug Delivery Reviews|February 25, 2020
Therapeutic genome editing in cardiovascular diseasesMasataka Nishiga, Lei S Qi, Joseph C Wu
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2021
CRISPRi/a Screening with Human iPSCsMasataka Nishiga, Lei S Qi, Joseph C Wu
Circulation Research|March 31, 2022
Ferroptosis of Pacemaker Cells in COVID-19Masataka Nishiga, James W S Jahng, Joseph C Wu
Nature Reviews. Cardiology|February 11, 2022
The use of new CRISPR tools in cardiovascular research and medicineMasataka Nishiga, Chun Liu, Lei S Qi, et al.
Trends in Genetics : TIG|September 12, 2021
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCsHongchao Guo, Lichao Liu, Masataka Nishiga, et al.
Cardiovascular Intervention and Therapeutics|April 15, 2014
Acute myocardial infarction and 30-year coronary aneurysm follow-up by serial angiography in a young adult with Kawasaki diseaseKazuki Matsushita, Toshihiro Tamura, Masataka Nishiga, et al.
Nature Reviews. Cardiology|July 22, 2020
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectivesMasataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews. Drug Discovery|May 15, 2024
Tackling the challenges of new approach methods for predicting drug effects from model systemsPaul D Pang, Syed Mukhtar Ahmed, Masataka Nishiga, et al.
Pageof 5